Celldex Therapeutics Inc (FRA:TCE2)
€ 33.01 +1.16 (+3.64%) Market Cap: 2.64 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 5.60 GF Score: 58/100

Celldex Therapeutics Inc (FRA:TCE2) Transcripts

  • 1